31 results on '"Andari E"'
Search Results
2. COMPARATIVE BEHAVIOR: Oxytocin-dependent consolation behavior in rodents
- Author
-
Burkett, J. P., Andari, E., Johnson, Z. V., Curry, D. C., de Waal, F. B. M., and Young, L. J.
- Published
- 2016
- Full Text
- View/download PDF
3. Analisis Kualitas Pelayanan terhadap Kepuasan Pasien Berobat di Puskesmas Desa Pasir Utama
- Author
-
andari, E. (efi), andari, E. (efi), 'Aini, Y. (Yulfita), Asrori, A. (Asrori), andari, E. (efi), andari, E. (efi), 'Aini, Y. (Yulfita), and Asrori, A. (Asrori)
- Abstract
This research was conducted to analyze the effect of service quality to satisfaction of patients treated at the healthy center in Desa Pasir utama. The samples in this research are 44 respondents. There were methods of sampling used the technique Accidentals also. The method analysis was quantitative analysis used validity test, reliability test, simple linear regression analysis, the correlation coefficient, coefficient of determination, and hypothesis testing. Used simple linear regression analysis concluded that service quality effect on patient satisfaction, it can be seen from the results of the regression equation with the result Y = 4,421+ 0,589XX, value indicates that the X or the service quality effect on customer satisfaction by 0.589 or 58.9%. Based on the calculation of correlation coefficients obtained results sig (2-tailed) of 0.058 means that the relationships between the two variables are low. The coefficient of determination shows the influence of variable X to variable Y is strong. Hypothesis test figures obtained significance of 0.000. It means that there were influenced quality of service to the satisfaction of the patient, because 0,000 <0.05 it means the value of regression is feasible or correct. It is recommended to the chairman of the health center in Desa Pasir Utama to be more concerned about the quality of services provided by employees of health centers so that patients get satisfaction in accordance with what they expect, and the need for modern facilities in order to hold a health center can be trusted by the local community.
- Published
- 2015
4. Le rôle de l’ocytocine dans l’autisme
- Author
-
Andari, E., primary, Schneider, F., additional, Vindras, P., additional, Mottolese, R., additional, Leboyer, M., additional, and Sirigu, A., additional
- Published
- 2012
- Full Text
- View/download PDF
5. Oxytocin's fingerprints in social deficits of autism spectrum disorders
- Author
-
Andari, E., primary, Schneider, F., additional, Vindras, P., additional, Mottolese, R., additional, Leboyer, M., additional, and Sirigu, A., additional
- Published
- 2012
- Full Text
- View/download PDF
6. A Large-Scale Statistical Analysis of Barefoot Impressions.
- Author
-
Kennedy, Robert B., Sanping Chen, Pressman, Irwin S., Yamashita, A. Brian, and Pressman, Andari E.
- Subjects
FOOTPRINTS ,ANTHROPOMETRY ,PHYSICAL anthropology ,BIOMETRIC identification ,CRIMINAL anthropology ,WALKING ,FORENSIC sciences - Abstract
Studies the outlines of footprints of persons walking normally to determine whether different people make verifiably distinct footprints. Basic null hypothesis; Rigorous mathematical framework for calculating worst case and average chance-match probabilities; Expanded popular sample size compared to previous studies by the authors; Automated tracing procedure for extracting all numerical measures.
- Published
- 2005
- Full Text
- View/download PDF
7. Psychological characteristics and emotional difficulties underlying school refusal in adolescents using functional near-infrared spectroscopy.
- Author
-
Li G, Niu Y, Liang X, Andari E, Liu Z, and Zhang KR
- Subjects
- Humans, Adolescent, Child, Depression diagnosis, Depression psychology, Anxiety Disorders, Schools, Spectroscopy, Near-Infrared, Emotions
- Abstract
Background: This study aims to explore the psychological characteristics, related emotional problems and potential NIR brain function mechanism of adolescents who refuse to attend school., Methods: The study included 38 adolescents (12-18 years old) who were not attending school and 35 healthy controls (12-18 years old) who are attending school regularly. Participants completed (1) general demographics, (2) Eysenck Personality Questionnaire (EPQ), (3) Zung Self-Rating Depression Scale (SDS), (4) Zung Self-Rating Anxiety Scale (SAS), and (5) Symptom Checklist-90 (SCL-90). In addition to the clinical tests, participants completed functional near-infrared spectroscopy (fNIRS). Mental health, personality, and emotional state were evaluated in both groups to explore the differences and to understand the underlying mechanisms of school refusal during adolescence., Results: Adolescents who did not attend school had higher neuroticism scores on the Eysenck Personality Questionnaire than healthy controls (p(FDR) < 0.001), introversion and concealment scores were lower than those of healthy controls (p(FDR) < 0.001), there was no significant difference in psychoticism scores between groups. SDS, SAS, SCL-90 scores and factor scores were higher than those of healthy control group (p(FDR) < 0.001), NIR functional brain imaging was different from healthy control group in the 12 and 27 channels (p(FDR) = 0.030, p(FDR) = 0.018), and no difference was found in the remaining channels (p(FDR) > 0.05). There were statistically significant differences in age and gender between the adolescents who refused school and the control group (p(FDR) < 0.001)., Conclusion: School refusal adolescents are relatively introverted and sensitive and need more attention in daily life. Although the adolescents' emotional problems did not reach the diagnostic criteria of depressive disorder and anxiety disorder, their scores were still higher than those of the control group, suggesting that we should pay more attention to their emotional problems in order to better help them return to school. Using fNIRS, it was found that abnormalities in frontal lobe regions in adolescents with school refusal behaviors, which would contribute to early diagnosis and timely intervention of school refusal behaviors., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
8. Developmental pyrethroid exposure causes a neurodevelopmental disorder phenotype in mice.
- Author
-
Curtis MA, Dhamsania RK, Branco RC, Guo JD, Creeden J, Neifer KL, Black CA, Winokur EJ, Andari E, Dias BG, Liu RC, Gourley SL, Miller GW, and Burkett JP
- Abstract
Neurodevelopmental disorders (NDDs) are a widespread and growing public health challenge, affecting as many as 17% of children in the United States. Recent epidemiological studies have implicated ambient exposure to pyrethroid pesticides during pregnancy in the risk for NDDs in the unborn child. Using a litter-based, independent discovery-replication cohort design, we exposed mouse dams orally during pregnancy and lactation to the Environmental Protection Agency's reference pyrethroid, deltamethrin, at 3 mg/kg, a concentration well below the benchmark dose used for regulatory guidance. The resulting offspring were tested using behavioral and molecular methods targeting behavioral phenotypes relevant to autism and NDD, as well as changes to the striatal dopamine system. Low-dose developmental exposure to the pyrethroid deltamethrin (DPE) decreased pup vocalizations, increased repetitive behaviors, and impaired both fear conditioning and operant conditioning. Compared with control mice, DPE mice had greater total striatal dopamine, dopamine metabolites, and stimulated dopamine release, but no difference in vesicular dopamine capacity or protein markers of dopamine vesicles. Dopamine transporter protein levels were increased in DPE mice, but not temporal dopamine reuptake. Striatal medium spiny neurons showed changes in electrophysiological properties consistent with a compensatory decrease in neuronal excitability. Combined with previous findings, these results implicate DPE as a direct cause of an NDD-relevant behavioral phenotype and striatal dopamine dysfunction in mice and implicate the cytosolic compartment as the location of excess striatal dopamine., (© The Author(s) 2023. Published by Oxford University Press on behalf of National Academy of Sciences.)
- Published
- 2023
- Full Text
- View/download PDF
9. A resting state fMRI study of major depressive disorder with and without anxiety.
- Author
-
Li GZ, Liu PH, Zhang AX, Andari E, and Zhang KR
- Subjects
- Anxiety diagnostic imaging, Brain diagnostic imaging, Brain Mapping, Female, Gyrus Cinguli diagnostic imaging, Humans, Magnetic Resonance Imaging, Depressive Disorder, Major complications, Depressive Disorder, Major diagnostic imaging
- Abstract
Background: The neurobiology of the Major depressive disorder (MDD) with anxiety is still unclear. The present study aimed to explore the brain correlates of MDD with and without anxiety in men and women during resting-state fMRI., Methods: Two hundred and fifty-four patients with MDD (MDD with anxiety, N = 152) and MDD without anxiety, N = 102) and 228 healthy controls (HCs) participated in this study. We compared the fALFF(fractional amplitude of low-frequency fluctuations) and ReHo(regional homogeneity) of ACC(anterior cingulate cortex) and insula among these three groups. We also compared gender difference between MDD with anxiety and MDD without anxiety., Results: We found that the fALFF values within the ACC and insula were significantly lower in MDD with anxiety compared to without anxiety and HCs. However, we did not find differences in ReHo values among the three groups. In women, we found significant differences in fALFF values between MDD with and without anxiety. These differences were not observed in men., Conclusions: It is possible that MDD with anxiety show less spontaneous BOLD-fMRI signal intensity within the ACC and insula compared to MDD without anxiety, especially in women. The fALFF within the ACC and insula can be a potential biomarker for severe MDD phenotype., (Copyright © 2022. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
10. Prevalence, increase and predictors of family violence during the COVID-19 pandemic, using modern machine learning approaches.
- Author
-
Todorovic K, O'Leary E, Ward KP, Devarasetty PP, Lee SJ, Knox M, and Andari E
- Abstract
Background: We are facing an ongoing pandemic of coronavirus disease 2019 (COVID-19), which is causing detrimental effects on mental health, including disturbing consequences on child maltreatment and intimate partner violence., Methods: We sought to identify predictors of child maltreatment and intimate partner violence from 380 participants (mean age 36.67 ± 10.61, 63.2% male; Time 3: June 2020) using modern machine learning analysis (random forest and SHAP values). We predicted that COVID-related factors (such as days in lockdown), parents' psychological distress during the pandemic (anxiety, depression), their personality traits, and their intimate partner relationship will be key contributors to child maltreatment. We also examined if there is an increase in family violence during the pandemic by using an additional cohort at two time points (Time 1: March 2020, N = 434; mean age 35.67 ± 9.85, 41.69% male; and Time 2: April 2020, N = 515; mean age 35.3 ± 9.5, 34.33%)., Results: Feature importance analysis revealed that parents' affective empathy, psychological well-being, outdoor activities with children as well as a reduction in physical fights between partners are strong predictors of a reduced risk of child maltreatment. We also found a significant increase in physical punishment (Time 3: 66.26%) toward children, as well as in physical (Time 3: 36.24%) and verbal fights (Time 3: 41.08%) among partners between different times., Conclusion: Using modernized predictive algorithms, we present a spectrum of features that can have influential weight on prediction of child maltreatment. Increasing awareness about family violence consequences and promoting parenting programs centered around mental health are imperative., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Todorovic, O’Leary, Ward, Devarasetty, Lee, Knox and Andari.)
- Published
- 2022
- Full Text
- View/download PDF
11. New Avenues for Serotonin and Oxytocin as a Potential Combination Drug Treatment for Neuropsychiatric Disorders.
- Author
-
Andari E
- Subjects
- Brain metabolism, Humans, Receptors, Oxytocin metabolism, Serotonin, Oxytocin, Pharmaceutical Preparations
- Published
- 2021
- Full Text
- View/download PDF
12. The neural correlates of paternal consoling behavior and frustration in response to infant crying.
- Author
-
Rilling JK, Richey L, Andari E, and Hamann S
- Subjects
- Brain physiology, Fathers psychology, Humans, Infant, Infant Behavior, Male, Paternal Behavior physiology, Crying physiology, Frustration
- Abstract
Human fathers often form strong attachments to their infants that contribute to positive developmental outcomes. However, fathers are also the most common perpetrators of infant abuse, and infant crying is a known trigger. Research on parental brain responses to infant crying have typically employed passive listening paradigms. However, parents usually engage with crying infants. Therefore, we examined the neural responses of 20 new fathers to infant cries both while passively listening, and while actively attempting to console the infant by selecting soothing strategies in a video game format. Compared with passive listening, active responding robustly activated brain regions involved in movement, empathy and approach motivation, and deactivated regions involved in stress and anxiety. Fathers reporting more frustration had less activation in basal forebrain areas and in brain areas involved with emotion regulation (e.g., prefrontal cortex and the supplementary motor area). Successful consolation of infant crying activated regions involved in both action-outcome learning and parental caregiving (anterior and posterior cingulate cortex). Overall, results suggest that active responding to infant cries amplifies activation in many brain areas typically activated during passive listening. Additionally, paternal frustration during active responding may involve a combination of low approach motivation and low engagement of emotion regulation., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
13. Experts' opinion on the detection and management of prediabetes in Lebanon.
- Author
-
Andari E, Atallah P, Azar S, Echtay A, Jambart S, Saab C, Howlett HC, and Al-Naqshbandi M
- Subjects
- Adult, Expert Testimony, Fasting, Humans, Lebanon epidemiology, Diabetes Mellitus, Type 2 diagnosis, Diabetes Mellitus, Type 2 epidemiology, Diabetes Mellitus, Type 2 therapy, Prediabetic State diagnosis, Prediabetic State epidemiology, Prediabetic State therapy
- Abstract
Given that the complications of type 2 diabetes can start at an early stage, early detection and appropriate management of prediabetes are essential. We aimed to develop an expert opinion on prediabetes in Lebanon to pave the way for national guidelines tailored for the Lebanese population in the near future. A panel of seven diabetes experts conducted a thorough literature review and discussed their opinions and experiences before coming up with a set of preliminary recommendations for the detection and management of prediabetes in Lebanon. Lebanese physicians employ multiple tests for the diagnosis of prediabetes and no national cut-off values exist. The panel agreed that prediabetes screening should be focused on patients exceeding 45 years of age with otherwise no risk factors and on adults with risk factors. The panel reached that fasting plasma glucose (FPG) and HbA1c should be used for prediabetes diagnosis in Lebanon. FPG values of 100-125 mg/dL or HbA1c values of 5.7%-6.4% were agreed upon as indicative of prediabetes. For the management of prediabetes, a three-step approach constituting lifestyle modifications, pharmacological treatment and bariatric surgery is recommended. There should be more focus on research on prediabetes in Lebanon. This preliminary report will be further discussed with the Lebanese Society of Endocrinology, Diabetes and Lipids in 2021 in order to come up with the first Lebanese national guidelines for the detection and management of prediabetes in Lebanon.
- Published
- 2021
- Full Text
- View/download PDF
14. Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection.
- Author
-
Creeden JF, Imami AS, Eby HM, Gillman C, Becker KN, Reigle J, Andari E, Pan ZK, O'Donovan SM, McCullumsmith RE, and McCullumsmith CB
- Subjects
- Anti-Inflammatory Agents pharmacology, Fluoxetine pharmacology, Humans, Anti-Inflammatory Agents therapeutic use, Cytokine Receptor gp130 genetics, Cytokine Release Syndrome drug therapy, Fluoxetine therapeutic use, NF-kappa B p50 Subunit genetics, SARS-CoV-2, COVID-19 Drug Treatment
- Abstract
Hyperinflammatory response caused by infections such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases organ failure, intensive care unit admission, and mortality. Cytokine storm in patients with Coronavirus Disease 2019 (COVID-19) drives this pattern of poor clinical outcomes and is dependent upon the activity of the transcription factor complex nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) and its downstream target gene interleukin 6 (IL6) which interacts with IL6 receptor (IL6R) and the IL6 signal transduction protein (IL6ST or gp130) to regulate intracellular inflammatory pathways. In this study, we compare transcriptomic signatures from a variety of drug-treated or genetically suppressed (i.e. knockdown) cell lines in order to identify a mechanism by which antidepressants such as fluoxetine demonstrate non-serotonergic, anti-inflammatory effects. Our results demonstrate a critical role for IL6ST and NF-kappaB Subunit 1 (NFKB1) in fluoxetine's ability to act as a potential therapy for hyperinflammatory states such as asthma, sepsis, and COVID-19., (Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
15. Effects of Oxytocin on Emotion Recognition in Schizophrenia: A Randomized Double-Blind Pilot Study.
- Author
-
Andari E, Massa NM, Fargotstein MD, Taylor NB, Halverson DM, Owens AV, Currin DL, Bhattacharya A, Gitman D, Cuthbert BC, Young LJ, and Duncan EJ
- Subjects
- Administration, Intranasal, Adult, Case-Control Studies, Dose-Response Relationship, Drug, Double-Blind Method, Fixation, Ocular drug effects, Humans, Male, Middle Aged, Oxytocin administration & dosage, Pilot Projects, Social Perception drug effects, Emotions, Oxytocin pharmacology, Recognition, Psychology drug effects, Schizophrenia drug therapy
- Abstract
Background: Schizophrenia (SCZ) is a neurodevelopmental disorder that leads to poor social function. Oxytocin (OXT), a neuropeptide involved in social cognition, is a potential therapeutic agent for alleviating social dysfunction. Therefore, we investigated the effects of intranasal oxytocin (IN-OXT) on emotional processes in experimental interactive social contexts in individuals with SCZ., Methods: In a male-only parallel randomized placebo-controlled double-blind trial, we investigated the effects of IN-OXT (24 IU) on visual fixation on pictures of faces and emotion recognition in an interactive ball-tossing game that probed processing of social and nonsocial stimuli., Results: Intranasal oxytocin enhanced the recognition of emotions during an emotion-based ball-tossing game. This improvement was specific to the game that included social cue processing. Intranasal oxytocin did not affect eye gaze duration or gaze dwell time on faces in these patients., Conclusions: An acute low dose of IN-OXT had a modest effect on social cue processing and was limited to emotion recognition. Higher doses and long-term trials targeting emotional processing in SCZ may lead to improved social function., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
16. Genetic and epigenetic modulation of the oxytocin receptor and implications for autism.
- Author
-
Andari E and Rilling JK
- Subjects
- Epigenesis, Genetic, Humans, Oxytocin genetics, Oxytocin metabolism, Receptors, Oxytocin genetics, Receptors, Oxytocin metabolism, Social Behavior, Autism Spectrum Disorder genetics, Autistic Disorder genetics
- Published
- 2021
- Full Text
- View/download PDF
17. The promiscuity of the oxytocin-vasopressin systems and their involvement in autism spectrum disorder.
- Author
-
Borie AM, Theofanopoulou C, and Andari E
- Subjects
- Animals, Humans, Oxytocin, Social Behavior, Vasopressins, Autism Spectrum Disorder, Autistic Disorder
- Abstract
Oxytocin and vasopressin systems have been studied separately in autism spectrum disorder (ASD). Here, we provide evidence from an evolutionary and neuroscience perspective about the shared mechanisms and the common roles in regulating social behaviors. We first discuss findings on the evolutionary history of oxytocin and vasopressin ligands and receptors that highlight their common origin and clarify the evolutionary background of the crosstalk between them. Second, we conducted a comprehensive review of the increasing evidence for the role of both neuropeptides in regulating social behaviors. Third, we reviewed the growing evidence on the associations between the oxytocin/vasopressin systems and ASD, which includes oxytocin and vasopressin dysfunction in animal models of autism and in human patients, and the impact of treatments targeting the oxytocin or the vasopressin systems in children and in adults. Here, we highlight the potential of targeting the oxytocin/vasopressin systems to improve social deficits observed in ASD and the need for further investigations on how to transfer these research innovations into clinical applications., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
18. Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.
- Author
-
Imami AS, O'Donovan SM, Creeden JF, Wu X, Eby H, McCullumsmith CB, Uvnäs-Moberg K, McCullumsmith RE, and Andari E
- Subjects
- Adaptive Immunity genetics, Betacoronavirus immunology, COVID-19, Cell Line, Coronavirus Infections genetics, Coronavirus Infections immunology, Coronavirus Infections virology, Databases, Genetic, Host-Pathogen Interactions, Humans, Oxytocin pharmacology, Pandemics, Pneumonia, Viral genetics, Pneumonia, Viral immunology, Pneumonia, Viral virology, SARS-CoV-2, T-Lymphocytes immunology, T-Lymphocytes virology, Transcriptome, COVID-19 Drug Treatment, Adaptive Immunity drug effects, Anti-Inflammatory Agents pharmacology, Betacoronavirus drug effects, Coronavirus Infections drug therapy, Gene Expression Profiling, Oxytocin analogs & derivatives, Pneumonia, Viral drug therapy, T-Lymphocytes drug effects
- Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic, infecting over 16 million people worldwide with a significant mortality rate. However, there is no current Food and Drug Administration-approved drug that treats coronavirus disease 2019 (COVID-19). Damage to T lymphocytes along with the cytokine storm are important factors that lead to exacerbation of clinical cases. Here, we are proposing intravenous oxytocin (OXT) as a candidate for adjunctive therapy for COVID-19. OXT has anti-inflammatory and proimmune adaptive functions. Using the Library of Integrated Network-Based Cellular Signatures (LINCS), we used the transcriptomic signature for carbetocin, an OXT agonist, and compared it to gene knockdown signatures of inflammatory (such as interleukin IL-1β and IL-6) and proimmune markers (including T cell and macrophage cell markers like CD40 and ARG1). We found that carbetocin's transcriptomic signature has a pattern of concordance with inflammation and immune marker knockdown signatures that are consistent with reduction of inflammation and promotion and sustaining of immune response. This suggests that carbetocin may have potent effects in modulating inflammation, attenuating T cell inhibition, and enhancing T cell activation. Our results also suggest that carbetocin is more effective at inducing immune cell responses than either lopinavir or hydroxychloroquine, both of which have been explored for the treatment of COVID-19.
- Published
- 2020
- Full Text
- View/download PDF
19. Epigenetic modification of the oxytocin receptor gene: implications for autism symptom severity and brain functional connectivity.
- Author
-
Andari E, Nishitani S, Kaundinya G, Caceres GA, Morrier MJ, Ousley O, Smith AK, Cubells JF, and Young LJ
- Subjects
- Adult, Brain diagnostic imaging, Brain metabolism, Humans, Oxytocin metabolism, Site-Specific DNA-Methyltransferase (Adenine-Specific), Autism Spectrum Disorder genetics, Autistic Disorder genetics, Epigenesis, Genetic, Receptors, Oxytocin genetics, Receptors, Oxytocin metabolism
- Abstract
The role of oxytocin in social cognition has attracted tremendous interest in social neuroscience and psychiatry. Some studies have reported improvement in social symptoms following oxytocin treatment in autism spectrum disorders (ASD), while others point to endogenous factors influencing its efficiency and to mixed results in terms of long-term clinical benefits. Epigenetic modification to the oxytocin receptor gene (OXTR) in ASD could be an informative biomarker of treatment efficacy. Yet, little is known about the relationship between OXTR methylation, clinical severity, and brain function in ASD. Here, we investigated the relationship between OXTR methylation, ASD diagnosis (in N = 35 ASD and N = 64 neurotypical group), measures of social responsiveness, and resting-state functional connectivity (rsFC) between areas involved in social cognition and reward processing (in a subset of ASD, N = 30). Adults with ASD showed higher OXTR methylation levels in the intron 1 area compared with neurotypical subjects. This hypermethylation was related to clinical symptoms and to a hypoconnectivity between cortico-cortical areas involved in theory of mind. Methylation at a CpG site in the exon 1 area was positively related to social responsiveness deficits in ASD and to a hyperconnectivity between striatal and cortical brain areas. Taken together, these findings provide initial evidence for OXTR hypermethylation in the intron area as a potential biomarker for adults with ASD with less severe developmental communication deficits, but with impairments in theory of mind and self-awareness. Also, OXTR methylation in the exon 1 area could be a potential biomarker of sociability sensitive to life experiences.
- Published
- 2020
- Full Text
- View/download PDF
20. Diabetes without Manifest Cardiovascular Disease: A Novel Approach in Risk Stratification and Treatment Selection.
- Author
-
Andari E, Arnaout S, Azar ST, Chammas E, Jambart S, Saleh M, Nemr R, and Sarkis A
- Subjects
- Algorithms, Calcium analysis, Cardiovascular Diseases diagnosis, Cardiovascular Diseases etiology, Consensus, Coronary Vessels diagnostic imaging, Diabetes Mellitus, Type 2 complications, Glucagon-Like Peptide-1 Receptor agonists, Humans, Mass Screening, Patient Selection, Protective Agents therapeutic use, Risk Assessment, Sodium-Glucose Transporter 2 Inhibitors therapeutic use, Tomography, X-Ray Computed, Cardiovascular Agents therapeutic use, Cardiovascular Diseases diagnostic imaging, Cardiovascular Diseases prevention & control, Diabetes Mellitus, Type 2 drug therapy, Hypoglycemic Agents therapeutic use
- Abstract
Background: Cardiovascular disease (CVD), the main macro vascular complication of type 2 diabetes (T2D), increases the risk of death significantly in patients with T2D., Introduction: Most of the patients with T2D do not have obvious CVD symptoms. Due to the paucity of data, CVD screening in asymptomatic patients with T2D remains highly controversial., Methods: This has driven a panel of experts to establish a novel consensus on how to approach patients with T2D at high CVD risk. The panel formulated a stepwise algorithm by which patients with T2D undergo initial risk stratification into low, intermediate and high risk using the ASCVD calculator. In patients with intermediate risk, coronary artery calcium measurement is used to further stratify those patients into new low and high-risk categories., Results and Conclusion: The panel recommends using standard diabetes care in low risk patients and using SGLT2 inhibitors and GLP1 agonists with cardio protective effect, on top of standard care, in high risk individuals., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2020
- Full Text
- View/download PDF
21. The Role of Amygdala in Patients With Euthymic Bipolar Disorder During Resting State.
- Author
-
Li G, Liu P, Andari E, Zhang A, and Zhang K
- Abstract
The current study aims to explore the functional changes of the amygdala in patients with euthymic Bipolar Disorder (BD) using resting state fMRI (rs-fMRI). Twenty-one euthymic patients with bipolar disorder and 28 healthy controls participated in this study. Two of the euthymic patients with BD and three of the healthy controls were excluded due to excessive head motion. We found that patients with euthymia (38.79 ± 12.03) show higher fALFF (fractional Amplitude of low-frequency fluctuation) value of the amygdala ( t = 2.076, P = 0.044), and lower functional connectivity between the amygdala and supplementary motor area ( p < 0.01, GRF corrected) than healthy controls (33.40 ± 8.21). However, euthymic patients did not show a differential activity in ReHo (Regional Homogeneity) and gray matter of the amygdala region as compared to healthy controls. Thus, despite the absence of clinical symptoms in euthymic patients with BD, the amygdala functional activity and its connectivity to other brain regions remain altered. Further investigation of negative emotions and social functioning in euthymic patients with BD are needed and can help pave the way for a better understanding of BD psychopathology.
- Published
- 2018
- Full Text
- View/download PDF
22. RDoC-based categorization of amygdala functions and its implications in autism.
- Author
-
Hennessey T, Andari E, and Rainnie DG
- Subjects
- Humans, National Institute of Mental Health (U.S.), Research, United States, Valproic Acid metabolism, Amygdala physiopathology, Autistic Disorder metabolism, Autistic Disorder physiopathology, Cognition physiology, Oxytocin metabolism
- Abstract
Confusion endures as to the exact role of the amygdala in relation to autism. To help resolve this we turned to the NIMH's Research Domain Criteria (RDoC) which provides a classification schema that identifies different categories of behaviors that can turn pathologic in mental health disorders, e.g. autism. While RDoC incorporates all the known neurobiological substrates for each domain, this review will focus primarily on the amygdala. We first consider the amygdala from an anatomical, historical, and developmental perspective. Next, we examine the different domains and constructs of RDoC that the amygdala is involved in: Negative Valence Systems, Positive Valence Systems, Cognitive Systems, Social Processes, and Arousal and Regulatory Systems. Then the evidence for a dysfunctional amygdala in autism is presented with a focus on alterations in development, prenatal valproic acid exposure as a model for ASD, and changes in the oxytocin system therein. Finally, a synthesis of RDoC, the amygdala, and autism is offered, emphasizing the task of disambiguation and suggestions for future research., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
23. A Precision Medicine Approach to Oxytocin Trials.
- Author
-
Andari E, Hurlemann R, and Young LJ
- Subjects
- Brain drug effects, Fear drug effects, Humans, Oxytocin administration & dosage, Precision Medicine, Social Behavior, Anxiety Disorders drug therapy, Autistic Disorder drug therapy, Clinical Trials as Topic, Oxytocin therapeutic use
- Abstract
In this chapter, we introduce a new area of social pharmacology that encompasses the study of the role of neuromodulators in modulating a wide range of social behaviors and brain function, with the interplay of genetic and epigenetic factors. There are increasing evidences for the role of the neuropeptide oxytocin in modulating a wide range of social behaviors, in reducing anxiety, and in impacting the social brain network. Oxytocin also promotes social functions in patients with neuropsychiatric disorders, such as autism and reduces anxiety and fear in anxiety disorders. In this chapter, we will emphasize the importance of integrating basic research and clinical human research in determining optimal strategies for drug discoveries for social dysfunctions and anxiety disorders. We will highlight the significance of adopting a precision medicine approach to optimize targeted treatments with oxytocin in neuropsychiatry. Oxytocin effects on social behavior and brain function can vary from one individual to another based on external factors, such as heterogeneity in autism phenotype, childhood experiences, personality, attachment style, and oxytocin receptor polymorphisms. Hence, targeted therapies for subgroups of patients can help alleviating some of the core symptoms and lead to a better future for these patients and their families.
- Published
- 2018
- Full Text
- View/download PDF
24. Brief Report: Relationship Between ADOS-2, Module 4 Calibrated Severity Scores (CSS) and Social and Non-Social Standardized Assessment Measures in Adult Males with Autism Spectrum Disorder (ASD).
- Author
-
Morrier MJ, Ousley OY, Caceres-Gamundi GA, Segall MJ, Cubells JF, Young LJ, and Andari E
- Subjects
- Adult, Autism Spectrum Disorder psychology, Calibration, Humans, Male, Psychometrics, Reproducibility of Results, Autism Spectrum Disorder diagnosis, Psychiatric Status Rating Scales standards, Severity of Illness Index
- Abstract
The ADOS-2 Modules 1-3 now include a standardized calibrated severity score (CSS) from 1 to 10 based on the overall total raw score. Subsequent research published CSS for Module 4 (Hus, Lord, Journal of Autism and Developmental Disorders 44(8):1996-2012, 2014); however more research is needed to examine the psychometric properties of this CSS. Forty males with ASD completed an assessment battery consisting of ADOS-2 Module 4 and other clinical measures assessing core ASD symptomology and comorbidity. Pearson correlation analyses found that CSS did not correlate with measures that assessed core social deficits of ASD or general psychiatric co-morbidity, but CSS did correlate negatively with intellectual quotient. These findings provide information on the limitations and relevance of CSS to be taken into account in future clinical evaluations of ASD.
- Published
- 2017
- Full Text
- View/download PDF
25. Insulin Detemir in Combination with Oral Antidiabetic Drugs Improves Glycemic Control in Persons with Type 2 Diabetes in Near East Countries: Results from the Lebanese Subgroup.
- Author
-
Echtay A, Andari E, Atallah P, Moufarrege R, and Nemr R
- Subjects
- Administration, Oral, Adult, Aged, Blood Glucose metabolism, Diabetes Mellitus, Type 2 blood, Drug Therapy, Combination, Female, Glycated Hemoglobin analysis, Humans, Insulin, Long-Acting, Male, Middle Aged, Prospective Studies, Young Adult, Developing Countries, Diabetes Mellitus, Type 2 drug therapy, Hypoglycemic Agents administration & dosage, Insulin Detemir administration & dosage
- Abstract
Objective: To evaluate the effectiveness and safety of insulin detemir treatment as add-on therapy in a real-world setting of Lebanese insulin naïve persons, with type 2 diabetes poorly controlled on oral antidiabetic drugs (OADs)., Methods: Our study was a prospective, observational study representing the Lebanese arm of the multinational prospective and observational study involving 2,155 persons across Near East countries, Lebanon, Pakistan, Israel and Jordan. Effectiveness endpoints were changes in HbA1c, fasting and post-prandial glucose (FPG, PPG) after 24 weeks of treatment with insulin detemir in eligible persons. Safety endpoints were number of hypoglycemic events, incidence of adverse drug reactions (ADRs), serious ADRs, adverse events, and body weight change between baseline and end of treatment., Results: 868 persons were included (mean age: 59.5 ± 10.4 years, men: 55.3%). Glycemic control improved with significant reduction in mean HbA1c from 9.7 ± 1.6% to 7.2 ± 1% (P<.0001). The percentage of persons who achieved the target of HbA1c<7% increased from .7% at baseline to 39% at week 24. Mean FPG decreased significantly from 213.7 ± 60.1 mg/dL to 120.3 ± 25.7 mg/dL (P<.001), and mean PPG from 271 ± 65.3 mg/dL to 158.1 ± 36.4 mg/dL (P<.0001). The rate of major hypoglycemic episodes decreased from .1498 at baseline to .0448 at week 24. Three adverse events but no ADR or serious ADR were reported. Body weight decreased from 80.4±13.2 Kg to 79.9±12.5 Kg (P<.0001)., Conclusions: Initiating insulin detemir in a clinical health care setting among Lebanese with type 2 diabetes mellitus on OADs improves glycemic control with no increase in hypoglycemia, adverse events or weight compared with baseline., Competing Interests: Conflicts of Interest: None declared.
- Published
- 2017
- Full Text
- View/download PDF
26. Adaptive coding of the value of social cues with oxytocin, an fMRI study in autism spectrum disorder.
- Author
-
Andari E, Richard N, Leboyer M, and Sirigu A
- Subjects
- Administration, Intranasal methods, Amygdala drug effects, Female, Humans, Interpersonal Relations, Magnetic Resonance Imaging methods, Male, Oxytocin administration & dosage, Autism Spectrum Disorder drug therapy, Cues, Emotions drug effects, Oxytocin pharmacology, Social Behavior
- Abstract
The neuropeptide oxytocin (OT) is one of the major targets of research in neuroscience, with respect to social functioning. Oxytocin promotes social skills and improves the quality of face processing in individuals with social dysfunctions such as autism spectrum disorder (ASD). Although one of OT's key functions is to promote social behavior during dynamic social interactions, the neural correlates of this function remain unknown. Here, we combined acute intranasal OT (IN-OT) administration (24 IU) and fMRI with an interactive ball game and a face-matching task in individuals with ASD (N = 20). We found that IN-OT selectively enhanced the brain activity of early visual areas in response to faces as compared to non-social stimuli. OT inhalation modulated the BOLD activity of amygdala and hippocampus in a context-dependent manner. Interestingly, IN-OT intake enhanced the activity of mid-orbitofrontal cortex in response to a fair partner, and insula region in response to an unfair partner. These OT-induced neural responses were accompanied by behavioral improvements in terms of allocating appropriate feelings of trust toward different partners' profiles. Our findings suggest that OT impacts the brain activity of key areas implicated in attention and emotion regulation in an adaptive manner, based on the value of social cues., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
27. The Need for a Theoretical Framework of Social Functioning to Optimize Targeted Therapies in Psychiatric Disorders.
- Author
-
Andari E
- Subjects
- Humans, Mental Disorders psychology, Mental Disorders therapy, Social Adjustment
- Published
- 2016
- Full Text
- View/download PDF
28. Editorial: Oxytocin's routes in social behavior: into the 21st century.
- Author
-
Andari E
- Published
- 2015
- Full Text
- View/download PDF
29. Oxytocin's fingerprint in personality traits and regional brain volume.
- Author
-
Andari E, Schneider FC, Mottolese R, Vindras P, and Sirigu A
- Subjects
- Adolescent, Adult, Amygdala anatomy & histology, Extraversion, Psychological, Female, Functional Laterality, Hippocampus anatomy & histology, Humans, Magnetic Resonance Imaging, Male, Nerve Fibers, Unmyelinated, Organ Size, Personality Tests, Young Adult, Brain anatomy & histology, Oxytocin blood, Personality physiology
- Abstract
Oxytocin has a fundamental role in social behavior. In humans, supporting evidence shows that oxytocin enhances people's ability to trust or affiliate with others. A key question is whether differences in plasma oxytocin concentration in humans are related to people's differences in their social traits of personality and if such differences are reflected in the structural organization of brain areas responsive to the action of this hormone. We examined the correlation between oxytocin plasma levels and personality traits in 30 healthy subjects, tested with the Inventory revised neuroticism-extroversion-openness personality inventory (NEO-PI-R). By using the voxel-based morphometry technique, we also investigated changes in gray matter volume as a function of the plasma oxytocin level and NEO-PI-R scores. A positive correlation was found between plasma oxytocin and extraversion scores, a dimension that captures social affiliative tendencies. Moreover, we found an inverse correlation between plasma oxytocin and the volume of the right amygdala and the right hippocampus, 2 brain areas implicated in fear and anxiety. Finally, we showed that the amygdala-hippocampal complex correlate negatively with extraversion scores. Our findings provide evidence for a neural mechanism linking physiological oxytocin's variability and structural variation of brain regions relevant for emotion regulation to individual differences in affiliative personality traits.
- Published
- 2014
- Full Text
- View/download PDF
30. Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries.
- Author
-
Echtay A, Tsur A, Hasan MI, Abu-Hijleh MO, Al Khatib N, Andari E, Atallah P, Qureshi S, Zafar J, Sandalci L, Ademogulları A, Haddad J, and Dagan B
- Abstract
Introduction: This study aimed at determining the clinical safety and efficacy of insulin detemir (IDet) in combination with oral anti-diabetic drugs (OADs) in type 2 diabetes (T2D) patients from four Near East Countries (Israel, Jordan, Pakistan and Lebanon)., Methods: This prospective observational study included T2D patients previously on OADs and newly diagnosed patients initiating IDet with or without OADs, at the discretion of physicians. Safety objectives included evaluation of hypoglycemia and adverse drug reactions (ADRs) from baseline to Week 24. Efficacy outcomes included baseline to Week 24 changes in glucose control parameters (glycated hemoglobin [HbA1c], fasting plasma glucose [FPG] and post-breakfast post-prandial plasma glucose [PPPG]). Change in body weight during this period was also assessed., Results: A total of 2,155 patients (mean ± SD: age 57.1 ± 11.0 years, BMI 29.4 ± 5.1 kg/m(2), average diabetes duration 9.2 ± 5.4 years) were included. IDet dose at baseline was 0.20 ± 0.09 U/kg titrated up to 0.34 ± 0.14 U/kg by Week 24. From baseline to Week 24, the total number of hypoglycemic episodes increased from 1.30 to 1.37 events/patient-year, while major hypoglycemic episodes decreased from 0.15 to 0.02 events/patient-year. A total of 9 ADRs were reported, of which one event was a serious ADR. Statistically significant improvements in glucose control were reported from baseline to Week 24 (HbA1c: 9.6 ± 1.6% vs. 7.6 ± 1.1%; FPG: 201.5 ± 59.5 mg/dL vs. 124.9 ± 31.6 mg/dL; PPPG: 264.2 ± 65.7 mg/dL vs. 167.2 ± 36.8 mg/dL; all p < 0.0001). Body weight did not change significantly after 24 weeks of IDet therapy., Conclusion: IDet therapy in combination with OADs improved glycemic control without increasing the risk of hypoglycemia or weight gain.
- Published
- 2013
- Full Text
- View/download PDF
31. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.
- Author
-
Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, and Sirigu A
- Subjects
- Administration, Inhalation, Adolescent, Adult, Autistic Disorder psychology, Emotions drug effects, Female, Humans, Male, Oxytocin administration & dosage, Oxytocin blood, Oxytocin pharmacology, Young Adult, Autistic Disorder drug therapy, Oxytocin therapeutic use, Social Behavior
- Abstract
Social adaptation requires specific cognitive and emotional competences. Individuals with high-functioning autism or with Asperger syndrome cannot understand or engage in social situations despite preserved intellectual abilities. Recently, it has been suggested that oxytocin, a hormone known to promote mother-infant bonds, may be implicated in the social deficit of autism. We investigated the behavioral effects of oxytocin in 13 subjects with autism. In a simulated ball game where participants interacted with fictitious partners, we found that after oxytocin inhalation, patients exhibited stronger interactions with the most socially cooperative partner and reported enhanced feelings of trust and preference. Also, during free viewing of pictures of faces, oxytocin selectively increased patients' gazing time on the socially informative region of the face, namely the eyes. Thus, under oxytocin, patients respond more strongly to others and exhibit more appropriate social behavior and affect, suggesting a therapeutic potential of oxytocin through its action on a core dimension of autism.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.